Discovery of selective low molecular weight interleukin-36 receptor antagonists by encoded library technologies

Juraj Velcicky1, Gregor Cremosnik2, Clemens Scheufler2

  • 1Novartis Biomedical Research, Novartis Campus, CH-4002, Basel, Switzerland. juraj.velcicky@novartis.com.

Nature Communications
|February 15, 2025
PubMed